Pacira Biosciences, Inc. (PCRX)
24.76
-0.29
(-1.16%)
USD |
NASDAQ |
Oct 06, 16:00
24.76
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences Market Cap : 986.00M for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 986.00M |
| October 05, 2026 | 997.55M |
| October 02, 2026 | 1.004B |
| October 01, 2026 | 995.96M |
| September 30, 2026 | 997.55M |
| September 29, 2026 | 1.021B |
| September 28, 2026 | 1.011B |
| September 25, 2026 | 1.000B |
| September 24, 2026 | 1.018B |
| September 23, 2026 | 980.82M |
| September 22, 2026 | 983.61M |
| September 21, 2026 | 960.12M |
| September 18, 2026 | 983.21M |
| September 17, 2026 | 974.85M |
| September 16, 2026 | 991.97M |
| September 15, 2026 | 958.92M |
| September 14, 2026 | 982.81M |
| September 11, 2026 | 1.010B |
| September 10, 2026 | 1.002B |
| September 09, 2026 | 1.031B |
| September 08, 2026 | 1.030B |
| September 04, 2026 | 1.049B |
| September 03, 2026 | 1.059B |
| September 02, 2026 | 1.058B |
| September 01, 2026 | 1.054B |
| Date | Value |
|---|---|
| August 31, 2026 | 1.031B |
| August 28, 2026 | 1.026B |
| August 27, 2026 | 1.029B |
| August 26, 2026 | 1.031B |
| August 25, 2026 | 1.017B |
| August 24, 2026 | 989.98M |
| August 21, 2026 | 982.42M |
| August 20, 2026 | 948.97M |
| August 19, 2026 | 970.07M |
| August 18, 2026 | 955.74M |
| August 17, 2026 | 925.47M |
| August 14, 2026 | 915.91M |
| August 13, 2026 | 923.08M |
| August 12, 2026 | 943.79M |
| August 11, 2026 | 970.87M |
| August 10, 2026 | 972.86M |
| August 07, 2026 | 996.35M |
| August 06, 2026 | 1.019B |
| August 05, 2026 | 990.38M |
| August 04, 2026 | 1.100B |
| August 03, 2026 | 1.072B |
| July 31, 2026 | 1.038B |
| July 30, 2026 | 1.060B |
| July 29, 2026 | 1.038B |
| July 28, 2026 | 1.054B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 613.57B |
| Liquidia Corp. | 2.309B |
| ANI Pharmaceuticals, Inc. | 1.643B |
| Corcept Therapeutics, Inc. | 12.90B |
| Veru, Inc. | 42.11M |
Market Cap Related Metrics
| PE Ratio | 71.33 |
| PS Ratio | 1.399 |
| Price to Book Value | 1.467 |
| Price to Free Cash Flow | 5.815 |
| Price | 24.76 |
| Earnings Yield | 1.40% |
| Operating PE Ratio | 37.78 |
| Normalized PE Ratio | 50.82 |